NCT04608006

Brief Summary

Over an 8-year period, 124 twin pregnancies at gestational age ≥32 weeks with both twins presenting as a vertex and eligible for vaginal delivery were reviewed. Excluded were patients with the following intrapartum factors which may affect mode of delivery of second twin: 1. Presentation of the 2nd twin: breech or other than vertex; 2. Monochorionic twins; 3. Induction of labour; 4. difference in foetal weight between twin B and twin A ≥25%. The chi-square statistic was used to compare differences in the incidence of retained second twin between the groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 3, 2014

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 24, 2019

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 29, 2020

Completed
Last Updated

October 30, 2020

Status Verified

October 1, 2020

Enrollment Period

5.1 years

First QC Date

October 23, 2020

Last Update Submit

October 29, 2020

Conditions

Keywords

EpiduralAnalgesiaLabour

Outcome Measures

Primary Outcomes (2)

  • Delivery of First twin

    Vaginal or C-Section

    24 hours

  • Delivery of Second twin

    C-Section or C-Section

    24 hours

Study Arms (3)

Vaginal Delivery

Delivered both twins vaginally

Drug: Bupivacaine-fentanyl

C-Section Delivery

Delivered both twins by Cesarean Section

Drug: Bupivacaine-fentanyl

Vaginal/C-Section Delivery

Delivery first twin vaginally and second twin By C-Section.

Drug: Bupivacaine-fentanyl

Interventions

Initial epidural bolus of 10 ml Bupivacaine 0.125% plus 50 mcg Fentanyl, followed by continuous infusion pf Bupivacaine 0.0625%™ plus 1mcg/dl Fentanyl

Also known as: Epidural Catheter insertion
C-Section DeliveryVaginal DeliveryVaginal/C-Section Delivery

Eligibility Criteria

Age16 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Women with twins pregnancy planned for trial of vaginal delivery and gave birth

You may qualify if:

  • gestational age of 32 weeks, determined by an early ultrasound performed in the second trimester or certain last menstrual period; (2) both twins viable; (3) eligibility for vaginal delivery as defined by twin A being cephalic; and (4) no previous cesarean section.

You may not qualify if:

  • underwent an elective or repeat cesarean section
  • presentation of twin B at delivery other than cephalic (breech, oblique or transverse presentation
  • induction of labour
  • the difference in foetal weight between twin B and twin A at delivery ≥25% .Neonates were excluded if one was stillborn or had major congenital malformations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut university faculty of medicine

Asyut, Egypt

Location

Related Publications (1)

  • Alexander JM, Sharma SK, McIntire DD, Leveno KJ. Epidural analgesia lengthens the Friedman active phase of labor. Obstet Gynecol. 2002 Jul;100(1):46-50. doi: 10.1016/s0029-7844(02)02009-4.

    PMID: 12100802BACKGROUND

MeSH Terms

Conditions

AgnosiaLabor Pain

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPain

Study Officials

  • Abdelrady S Ibrahim, M.D.

    Assiut University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assiut University Faculty of Medicine Anesthesia Dept

Study Record Dates

First Submitted

October 23, 2020

First Posted

October 29, 2020

Study Start

November 3, 2014

Primary Completion

December 24, 2019

Study Completion

December 24, 2019

Last Updated

October 30, 2020

Record last verified: 2020-10

Locations